These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22014981)

  • 1. Chemotherapy-induced iatrogenic injury of skin: new drugs and new concepts.
    Choi JN
    Clin Dermatol; 2011; 29(6):587-601. PubMed ID: 22014981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous side-effects in patients on long-term treatment with epidermal growth factor receptor inhibitors.
    Osio A; Mateus C; Soria JC; Massard C; Malka D; Boige V; Besse B; Robert C
    Br J Dermatol; 2009 Sep; 161(3):515-21. PubMed ID: 19466958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic effects of multiple anticancer drugs on skin.
    Kamil N; Kamil S; Ahmed SP; Ashraf R; Khurram M; Ali MO
    Pak J Pharm Sci; 2010 Jan; 23(1):7-14. PubMed ID: 20067860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous drug eruptions associated with the use of new oncological drugs.
    Belloni B; Schönewolf N; Rozati S; Goldinger SM; Dummer R
    Chem Immunol Allergy; 2012; 97():191-202. PubMed ID: 22613863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatologic toxicity of chemotherapeutic agents.
    Payne AS; James WD; Weiss RB
    Semin Oncol; 2006 Feb; 33(1):86-97. PubMed ID: 16473647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newly recognized cutaneous drug eruptions.
    Callen JP
    Dermatol Clin; 2007 Apr; 25(2):255-61, viii. PubMed ID: 17430762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor.
    Autier J; Escudier B; Wechsler J; Spatz A; Robert C
    Arch Dermatol; 2008 Jul; 144(7):886-92. PubMed ID: 18645140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin reactions to the new biologic anticancer drugs.
    Myskowski PL; Halpern AC
    Curr Opin Support Palliat Care; 2009 Dec; 3(4):294-9. PubMed ID: 19797958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined classic and iatrogenic Kaposi's sarcoma. Corticosteroid withdrawal can result in remission.
    Kroumpouzos G; Delaney T; Phillips TJ
    Postgrad Med; 2000 Aug; 108(2):103-6. PubMed ID: 10951749
    [No Abstract]   [Full Text] [Related]  

  • 10. Skin toxicity of anti-cancer therapy.
    Ulrich J; Hartmann JT; Dörr W; Ugurel S
    J Dtsch Dermatol Ges; 2008 Nov; 6(11):959-77. PubMed ID: 18992037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subacute cutaneous lupus erythematosus induced by the new multikinase inhibitor pazopanib.
    Casado-Verrier B; Pérez-Santos S; Delgado-Mucientes C; Beato-Merino M
    Br J Dermatol; 2014 Dec; 171(6):1559-61. PubMed ID: 24909204
    [No Abstract]   [Full Text] [Related]  

  • 12. Bullous subacute cutaneous lupus erythematosus.
    Perera GK; Black MM; McGibbon DH
    Clin Exp Dermatol; 2004 May; 29(3):265-7. PubMed ID: 15115507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse Drug Reactions of the Lower Extremities.
    Adigun CG
    Clin Podiatr Med Surg; 2016 Jul; 33(3):397-408. PubMed ID: 27215159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails.
    Lacouture M; Sibaud V
    Am J Clin Dermatol; 2018 Nov; 19(Suppl 1):31-39. PubMed ID: 30374901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous reactions to chemotherapy: commonly seen, less described, little understood.
    Sanborn RE; Sauer DA
    Dermatol Clin; 2008 Jan; 26(1):103-19, ix. PubMed ID: 18023774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy-induced acral erythema: a clinical and histopathologic study of 44 cases].
    Hueso L; Sanmartín O; Nagore E; Botella-Estrada R; Requena C; Llombart B; Serra-Guillén C; Alfaro-Rubio A; Guillén C
    Actas Dermosifiliogr; 2008 May; 99(4):281-90. PubMed ID: 18394404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel-induced acral erythema and nail changes distributed to photoexposed areas.
    Ferreira O; Baudrier T; Mota A; Duarte AF; Azevedo F
    Cutan Ocul Toxicol; 2010 Dec; 29(4):296-9. PubMed ID: 20608863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic erythema of chemotherapy: a useful clinical term.
    Bolognia JL; Cooper DL; Glusac EJ
    J Am Acad Dermatol; 2008 Sep; 59(3):524-9. PubMed ID: 18694683
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact and management of skin toxicity associated with anti-epidermal growth factor receptor therapy: survey results.
    Boone SL; Rademaker A; Liu D; Pfeiffer C; Mauro DJ; Lacouture ME
    Oncology; 2007; 72(3-4):152-9. PubMed ID: 18160805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized palmar-plantar epidermal hyperplasia: a previously undefined dermatologic toxicity to sorafenib.
    Beldner M; Jacobson M; Burges GE; Dewaay D; Maize JC; Chaudhary UB
    Oncologist; 2007 Oct; 12(10):1178-82. PubMed ID: 17962611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.